Modification of intestinal stimulatory effects of 5-hydroxytryptamine by adrenergic amines, prostaglandin E1 and theophylline.
D000818:Animals; D001626:Bethanechol Compounds / Q000494:pharmacology; D001679:Biogenic Amines / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D007421:Intestine, Small / Q000187:drug effects; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D008729:Methoxamine / Q000008:administration & dosage / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D011941:Receptors, Adrenergic; D012701:Serotonin / Q000494:pharmacology*; D013806:Theophylline / Q000008:administration & dosage / Q000494:pharmacology*
D001626:Bethanechol Compounds; D001679:Biogenic Amines; D010879:Piperazines; D011453:Prostaglandins; D011941:Receptors, Adrenergic; D012701:Serotonin; D013806:Theophylline; D000242:Cyclic AMP; D008729:Methoxamine; D007545:Isoproterenol; D009638:Norepinephrine